Home・Aktien・Cerus Corp

Cerus Corp

Geschlossen

BrancheGesundheitswesen

2.84 5.19

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.69

Max

2.89

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.3M -3M
Verkäufe	-2.5M 57M
EPS	-0.01
Gewinnspanne	-5.191
Angestellte	261
EBITDA	-1.5M -712K

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+84.5% upside

Dividenden
By Acuity
Nächstes Ergebnis	5. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-107M 508M
Vorheriger Eröffnungskurs	-2.35
Vorheriger Schlusskurs	2.84

Nachrichtenstimmung

By Acuity

58%

42%

289 / 340 Ranking in Healthcare

Cerus Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Aug. 2026, 19:51 UTC

Macro Event

Cerus Corp is trading higher today, driven by a strong 30-Year Bond Auction yield. The stock has shown notable intraday volatility and high trading volume.

12. Aug. 2026, 20:01 UTC

Cerus Corp shares are higher Wednesday, continuing a seven-session upward trend. Earlier, the stock pulled back from a session high.

11. Aug. 2026, 20:02 UTC

Cerus Corp shares are gaining during Tuesday's session, with unusually high trading volume. No specific news has been identified to explain the movement.

10. Aug. 2026, 20:02 UTC

Cerus Corp shares are higher today, following broader market gains since Friday amid tempered interest rate hike expectations from a recent labor market report.

7. Aug. 2026, 23:56 UTC

Cerus Corp shares are higher in after-market trading, recovering from earlier declines amid shifting expectations for Federal Reserve interest rate hikes.

6. Aug. 2026, 19:46 UTC

Cerus Corp shares are higher in Thursday's session, having gained since Wednesday. The stock remains below its 20-day moving average.

5. Aug. 2026, 19:43 UTC

Cerus Corp shares are higher Wednesday, recovering from an earlier decline amid high trading volume. Broader market sentiment is influenced by ADP's employment report.

4. Aug. 2026, 19:11 UTC

Correlated Moves

Cerus Corp shares are higher amid increased trading volume and positive market trends, despite concerns over declining U.S. core factory orders.

3. Aug. 2026, 19:56 UTC

Correlated Moves

Cerus Corp shares are higher, supported by broader market strength and a rally in the health care supplies sector. The stock remains below its 20-day moving average.

31. Juli 2026, 23:06 UTC

Cerus Corp shares are higher in after-market trading, reflecting a notable increase since Friday's close, despite being below its 20-day moving average.

30. Juli 2026, 23:41 UTC

News

Cerus Corporation shares declined in after-market hours following a revenue miss and lowered full-year guidance, despite second-quarter earnings matching estimates.

29. Juli 2026, 19:56 UTC

Macro Event

Cerus Corp shares are lower as macroeconomic factors, including steady interest rates and rising oil prices, create market volatility. The stock is near its one-month low.

28. Juli 2026, 16:02 UTC

Cerus Corp shares are lower today, reflecting broader market pressures amid a risk-off sentiment following declines in tech-heavy indices like Japan's Nikkei 225.

27. Juli 2026, 20:07 UTC

Cerus Corp shares are higher in Monday's session, reaching a peak of 6.12%. Broader market factors include declining oil prices and lower Treasury yields.

24. Juli 2026, 19:06 UTC

Cerus Corp shares are higher, supported by a decline in crude oil prices that eased inflationary pressures. The stock remains below its 20-day moving average.

23. Juli 2026, 09:01 UTC

Cerus Corp shares are lower in pre-market hours, continuing a downward trend. The stock remains significantly below its 20-day moving average.

22. Juli 2026, 15:46 UTC

Cerus Corp. shares are trading roughly flat, with no specific news identified. The stock remains above its 20-day moving average after a month of gains.

21. Juli 2026, 21:41 UTC

Cerus Corp shares are lower in after-market hours, declining steadily after an early peak. No specific news was identified to explain the movement.

Peer-Vergleich

Kursveränderung

Cerus Corp Prognose

Kursziel

By TipRanks

84.5% Vorteil

12-Monats-Prognose

Durchschnitt 5 USD 84.5%

Hoch 5 USD

Tief 5 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cerus Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Cerus Corp – Dist abgegeben haben.

Stimmung

By Acuity

289 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.